Increased data output from the use of devices can accelerate trials for this therapeutic area in need of new therapies.
Victoria Hunter
Advertisement
Digital Biomarker Director, Koneksa
Articles by Victoria Hunter
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Artificial Intelligence in Clinical Trials: From Pilots to Practice
2
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5